A tissue culture-based breeding approach that generates genetic variation in cultivated strawberry to develop varieties resistant to 2,4-D, halosulfuron, and glyphosate. This method addresses the challenges of strawberry breeding, which is complicated by its allo-octoploid and highly heterozygous genome, offering growers improved weed management options.
Cultivated strawberry breeding is challenging due to its allo-octoploid and highly heterozygous genome, which limits traditional breeding approaches. This research program uses somaclonal variation, a technique that generates genetic mutations during tissue culture, as an alternative breeding tool for strawberry improvement. The project focuses on developing strawberry varieties resistant to three major herbicides used by growers and nurseries: 2,4-D, halosulfuron, and glyphosate. By leveraging established tissue culture protocols for major octoploid strawberry cultivars, the team generates large populations of somaclonal variants and selects clones with herbicide resistance traits.
Approach and methodology:
Key findings from preliminary validation:
Technical rationale:
The technology is at an early-to-mid stage of development. Tissue culture conditions have been established for major strawberry cultivars, and preliminary screening has demonstrated proof of concept for glyphosate resistance, with one resistant clone identified from 149 tested somaclones. The research team is refining screening protocols for 2,4-D and extending the approach to halosulfuron. Selected herbicide-resistant somaclones will be propagated in greenhouse conditions and subsequently tested under field conditions to validate performance in real-world agricultural settings.
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.